Fresh Tracks Therapeutics Inc Investor Relations Material
Latest events
Q3 2022
Fresh Tracks Therapeutics Inc
Q4 2023
15 Mar, 2024
Q3 2023
13 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Fresh Tracks Therapeutics Inc
Access all reports
Fresh Tracks Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for autoimmune, inflammatory, and other skin-related diseases. The company's pipeline includes small molecule and biologic drug candidates designed to target the underlying causes of these conditions. Fresh Tracks aims to provide new treatment options that address unmet medical needs in dermatology and immunology. The company serves the healthcare sector, specifically focusing on skin health and immune system disorders. The company is headquartered in Boulder, Colorado, and its shares are listed on the NASDAQ.
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
FRTX
Country
🇺🇸 United States